DOSSIER · 13F Holders · Q2 2026
BBIO 2.25 02/01/29
BRIDGEBIO PHARMA INC
44 institutions still hold BRIDGEBIO PHARMA INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 10806XAD4·44 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
44 institutions reported BBIO 2.25 02/01/29 in Q2 2026. LINDEN ADVISORS LP leads at 34.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
24 more holders available. Log in →